Evaluating the effectiveness of oral stripe and perl vitamin D in vitamin D deficiency

comparing the effect of oral stripe and vitamin D3 pearl, in patiens with vitamin D deficiency in single blind clinical trial

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

IRCT

Registry ID

IRCT20180408039235N1

Enrollment

Registered

2018-07-11

Start date

2018-05-22

Completion date

Unknown

Last updated

2018-09-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Vitamin D deficiency. Vitamin D deficiency, unspecified

Interventions

Intervention 1: Control group: Pearl recipients of vitamin D, For 30 patients, 50,000 units of vitamin D (zhravi company) once a week were administered orally for 8 weeks (control group) . Interventio

Eligibility

Sex/Gender

All

Age

7 Years to No maximum

Inclusion criteria

Inclusion criteria: Decreased vitamin D levels from normal range (32 ng / ml) Age of patients older than 7 years

Exclusion criteria

Exclusion criteria: Company dissatisfaction with the study Drinking alcohol or drugs The patient will not be able to use Perl vitamin D3 or oral strip Patients with hypercalciuria, hyperparathyroidism, hypothyroidism, patients taking anti-seizure drugs, anti-tuberculosis, typhylline and vitamin D supplements, and those with malabsorption syndrome, celiac disease, and liver and kidney failure

Design outcomes

Primary

Measure	Time frame
Measuring serum vitamin D levels. Timepoint: 8 Week. Method of measurement: Serum test.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAryan Yousefi Fard

Ahvaz University of Medical Sciences

yousefifard.a@ajums.ac.ir+98 61 3443 9992

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026